Login / Signup

A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia.

Iris de WeerdtRoeland LamerisJurjen M RubenRenate de BoerJan KloostermanLisa A KingMark-David LevinPaul W H I ParrenTanja D de GruijlArnon P KaterHans J van der Vliet
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Collectively, our data demonstrate the immunotherapeutic potential of this novel CD1d-specific Vγ9Vδ2-T cell engager in CLL.
Keyphrases
  • chronic lymphocytic leukemia
  • nk cells
  • bone marrow
  • electronic health record
  • cell therapy
  • big data
  • machine learning
  • risk assessment
  • human health
  • platelet rich plasma
  • data analysis